“Hidden Trials” In The Age Of Transparency: ClinicalTrials.gov Director Sees Room For Improvement
This article was originally published in RPM Report
Executive Summary
The global push towards clinical trial registration and transparency hasn’t ended the problem of “hidden trials,” the head of NIH’s ClinicalTrials.gov cautions. But the existence of registries helps better analyze the problem and offers some fairly simple steps to get closer to the goal of assuring that all clinical trials are available to the public.